Intra-Cellular Ther (ITCI)

The overall ratings of 11 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

16 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader Dec 2, 2016

The overall ratings of 16 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

26 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader Nov 11, 2016

The ratings of 26 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

14 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader Nov 4, 2016

This week, the ratings of 14 Pharmaceuticals stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

7 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader Oct 14, 2016

This week, 7 Pharmaceuticals stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader Oct 7, 2016

The ratings of 5 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Hottest Manufacturing Stocks Now – CATB AEGR BSPM QLTI

By Portfolio Grader Sep 29, 2016

The following stocks were the biggest movers and shakers in the Manufacturing sector today.

3 Stocks to Watch on Thursday: Pier 1 Imports Inc (PIR), Intra-Cellular Therapies Inc (ITCI) and Progress Software Corporation (PRGS)

By Karl Utermohlen, InvestorPlace Writer Sep 29, 2016

Intra-Cellular Therapies (INTC) is cratering on drug trial news, Pier 1 (PIR) lost less than expected and Progress Software (PRGS) disappointed Wall Street.

Intra-Cellular Ther (ITCI)

3 Biotech Stocks With Skyrocketing Potential: April 2024

3 Biotech Stocks That Could Be Multibaggers in the Making: February Edition

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Intra-Cellular Therapies News: Why ITCI Stock Is Skyrocketing 75% Today

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Intra-Cellular Ther (ITCI)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

ITCI Stock Predictions, Articles, and Intra-Cellular Ther News

Subscriber Sign in